Trial Profile
An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Allergan
- 17 Apr 2015 New trial record